Business Context and Reporting Period
This Form 8-K filing by The Chemours Company (Chemours) reports on events occurring on February 11, 2017, with the report filed on February 13, 2017. The filing addresses the settlement of multi-district litigation (MDL) involving approximately 3,500 personal injury lawsuits related to exposure to perfluorooctanoic acid (PFOA) at the Washington Works plant in West Virginia.
Key Financial Metrics
- Total Settlement Amount: $670.7 million in cash.
- Chemours Share of Settlement: $335.35 million (50% of total).
- DuPont Share of Settlement: $335.35 million (50% of total), not subject to indemnification by Chemours.
- Accrued Liability: Chemours had accrued $335.35 million for this matter as of December 31, 2016.
- Future Liability Sharing: A five-year agreement limits Chemours' annual payment for future PFOA liabilities to $25 million. DuPont covers the next $25 million of excess, with Chemours bearing any further excess.
Material Changes and Settlement Terms
On February 11, 2017, DuPont and Chemours entered into an agreement in principle to settle all filed and unfiled personal injury cases in the MDL. The settlement provides a complete release of claims by settling plaintiffs in exchange for the cash payment. The agreement is not an admission of liability. The settlement is not subject to court approval but requires the drafting of a master settlement agreement. DuPont retains a "walk-away" right to terminate the settlement if a specified number of plaintiffs opt out.
Outlook, Risks, and Contingencies
- Future Liabilities: Following the settlement, Chemours and DuPont will share potential future PFOA liabilities for five years under a tiered payment structure.
- Waiver of Defenses: Upon the settlement becoming effective, Chemours will not contest its liability to DuPont under the Separation Agreement for PFOA liabilities based on ostensible defenses (e.g., punitive damages, fines, attorneys' fees), though it retains defenses regarding whether specific claims fall within the indemnification scope.
- Risks: Forward-looking statements highlight risks regarding whether the settlement becomes effective, the performance of DuPont's obligations, and the outcome of any pending or future litigation not covered by the settlement.
Investor Verification Checklist
- Verify the final terms of the master settlement agreement, specifically the timing and logistics of the $335.35 million payment.
- Confirm the number of plaintiffs opting out to ensure DuPont does not exercise its walk-away right.
- Monitor the five-year liability sharing mechanism for future PFOA claims exceeding the $25 million annual threshold.
- Review the Separation Agreement to understand the scope of indemnification defenses Chemours has retained.